TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.

Akihito Kawazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.